Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Estey

Showing results (141-150 of 204) with videos related to

Pageof 21
Sort By:
Blood|May 1, 1996
Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acidE Estey, P F Thall, K Mehta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I studyM Beran, S Jeha, S O'Brien, et al.
Cancer|July 10, 2001
High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemiaJ Cortes, E Estey, S O'Brien, et al.
The American Journal of Medicine|December 1, 1992
Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemiaH M Kantarjian, T Smith, E Estey, et al.
Leukemia & Lymphoma|June 28, 2001
Comparison of amphotericin B lipid complex (ABLC) vs. ambisome in the treatment of suspected or documented fungal infections in patients with leukemiaR V Fleming, H M Kantarjian, R Husni, et al.
Blood|August 1, 1994
2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disordersS O'Brien, R Kurzrock, M Duvic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factorE Estey, P Thall, M Andreeff, et al.
Cancer|June 15, 1994
All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemiaJ E Cortes, H Kantarjian, S O'Brien, et al.
Leukemia & Lymphoma|June 1, 1993
Phase II clinical trial of fludarabine in chronic lymphocytic leukemia on a weekly low-dose scheduleA Kemena, S O'Brien, H Kantarjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosineM A Dimopoulos, H Kantarjian, D Weber, et al.
Pageof 21

Showing results (141-150 of 204) with videos related to

Sort By:
Pageof 21
Blood|May 1, 1996
Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acidE Estey, P F Thall, K Mehta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I studyM Beran, S Jeha, S O'Brien, et al.
Cancer|July 10, 2001
High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemiaJ Cortes, E Estey, S O'Brien, et al.
The American Journal of Medicine|December 1, 1992
Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemiaH M Kantarjian, T Smith, E Estey, et al.
Leukemia & Lymphoma|June 28, 2001
Comparison of amphotericin B lipid complex (ABLC) vs. ambisome in the treatment of suspected or documented fungal infections in patients with leukemiaR V Fleming, H M Kantarjian, R Husni, et al.
Blood|August 1, 1994
2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disordersS O'Brien, R Kurzrock, M Duvic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factorE Estey, P Thall, M Andreeff, et al.
Cancer|June 15, 1994
All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemiaJ E Cortes, H Kantarjian, S O'Brien, et al.
Leukemia & Lymphoma|June 1, 1993
Phase II clinical trial of fludarabine in chronic lymphocytic leukemia on a weekly low-dose scheduleA Kemena, S O'Brien, H Kantarjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosineM A Dimopoulos, H Kantarjian, D Weber, et al.
Pageof 21